n/a
Abstract Title:

Evidence of antidiabetic activity ofagainst streptozotocin-induced diabetic Wistar albino rats.

Abstract Source:

3 Biotech. 2018 Feb ;8(2):129. Epub 2018 Feb 13. PMID: 29450119

Abstract Author(s):

Jerine Peter Simon, Udhaya Lavinya Baskaran, Kadar Basha Shallauddin, Giridharan Ramalingam, Sabina Evan Prince

Article Affiliation:

Jerine Peter Simon

Abstract:

The aim of our study is to investigate the protective effect ofagainst streptozotocin-induced diabetes in Wistar albino rats. Rats were divided into five groups: group I was normal control, group II was diabetic control (50 mg/kg b.w. of streptozotocin, i.p.), group III was(400 mg/kg b.w., p.o.) treated diabetic rats; group IV was Glibenclamide (0. 6 mg/kg b.w., p.o.) treated diabetic rats and group V was treated with(400 mg/kg b.w., p.o.) alone. There was significant elevation in the levels of blood glucose, serum lipid profile and serum renal markers (total protein, urea, creatinine and uric acid) in the diabetic rats. Also, diabetic rats showed significantly ( < 0.05) reduced antioxidant status (reduced levels of superoxide dismutase, catalase, glutathione peroxidase, glutathione--transferase and reduced glutathione; increased levels of TBARS), impaired oral glucose tolerance and elevated HbA1C.was able to normalize the above mentioned parameters. Significant histopathological changes were found in the pancreas, liver and kidney sections of the diabetic control group while treatment withwas able to minimize the extent of tissue damage. Current study shows thatpossesses significant antidiabetic and antihyperlipidemic effects in streptozotocin-induced diabetic rats by effectively reducing the rise in blood glucose levels and lipid profile.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.